These novel therapies, including Semaglutide , Mounjaro , and Retatrutide , represent a important advancement in managing type 2 the condition and promoting weight loss . They operate by mimicking the body’s natural peptide GLP-1 , enabling to regulate blood levels and reduce hunger . Every medication has somewhat distinct characteristics and can